158 related articles for article (PubMed ID: 15177526)
1. Frequent nurse visits decrease white coat effect in stage III hypertension.
Guerra-Riccio GM; Artigas Giorgi DM; Consolin-Colombo FM; Barreto-Filho JA; Lopes HF; Fleury Camargo AL; Moacyr Krieger E
Am J Hypertens; 2004 Jun; 17(6):523-8. PubMed ID: 15177526
[TBL] [Abstract][Full Text] [Related]
2. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
4. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment.
Niiranen TJ; Kantola IM; Vesalainen R; Johansson J; Ruuska MJ
Am J Hypertens; 2006 May; 19(5):468-74. PubMed ID: 16647616
[TBL] [Abstract][Full Text] [Related]
5. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
6. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring.
Ben-Dov IZ; Perk G; Ben-Arie L; Mekler J; Bursztyn M
Am J Hypertens; 2004 Jun; 17(6):535-9. PubMed ID: 15177528
[TBL] [Abstract][Full Text] [Related]
7. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
8. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
10. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care.
Halme L; Vesalainen R; Kaaja M; Kantola I;
Am J Hypertens; 2005 Nov; 18(11):1415-20. PubMed ID: 16280273
[TBL] [Abstract][Full Text] [Related]
11. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
[TBL] [Abstract][Full Text] [Related]
12. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
Larkin KT; Schauss SL; Elnicki DM; Goodie JL
J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
[TBL] [Abstract][Full Text] [Related]
13. The 'ABPM effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring.
Calvo C; Hermida RC; Ayala DE; López JE; Fernández JR; Domínguez MJ; Mojón A; Covelo M
J Hypertens; 2003 Dec; 21(12):2265-73. PubMed ID: 14654746
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing white-coat effect.
Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
[TBL] [Abstract][Full Text] [Related]
15. White coat hypertension and white coat effect. Similarities and differences.
Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Zampi I; Gattobigio R; Sacchi N; Porcellati C
Am J Hypertens; 1995 Aug; 8(8):790-8. PubMed ID: 7576395
[TBL] [Abstract][Full Text] [Related]
16. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
Zheng S; Nath V; Coyne DW
Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
[TBL] [Abstract][Full Text] [Related]
17. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial.
White WB; Cleveland JM; Rolleri RL;
J Hum Hypertens; 2008 Aug; 22(8):559-68. PubMed ID: 18463672
[TBL] [Abstract][Full Text] [Related]
18. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
19. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K
Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
